MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Inicio・Lista de Acciones・Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp

Cerrado

17.49 -1.19

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

17.39

Máximo

17.65

Métricas clave
By Trading Economics
Ingresos	35M 9.5M
Ventas	35M 94M
Margen de beneficios	10.158
Empleados	619
EBITDA	35M 17M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+15.58% upside

Dividendos
By Dow Jones
Próximas Ganancias	10 feb 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	147M 2.8B
Apertura anterior	18.68
Cierre anterior	17.49

Puntuación técnica

By Trading Central

Confianza

Very Strong Bullish Evidence

8.81 / 10.18 Soporte y Resistencia

Adaptive Biotechnologies Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 ene 2026, 23:29 UTC

Acciones populares

Stocks to Watch: Atossa Therapeutics, Union Pacific

18 ene 2026, 23:57 UTC

Adquisiciones, fusiones, absorciones

Elliott: Standalone Plan Offers Clear Path to Valuation of More Than Y40,000 a Share by 2028

18 ene 2026, 23:57 UTC

Adquisiciones, fusiones, absorciones

Elliott: Opposing Toyota Fudosan's Revised Tender Offer for Toyota Industries

18 ene 2026, 23:55 UTC

Charlas de Mercado

Oil Falls as Middle East Tensions Continue to Fade -- Market Talk

18 ene 2026, 23:40 UTC

Charlas de Mercado

Precious Metals Climb After Trump Threatens Europe With Tariffs Over Greenland -- Market Talk

18 ene 2026, 22:29 UTC

Charlas de Mercado

Miners Seen Extending Rally as Generalist Investors Warm to Sector -- Market Talk

18 ene 2026, 21:03 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

18 ene 2026, 21:03 UTC

Charlas de Mercado

More Australian Voters Switch Away From Major Parties -- Market Talk

18 ene 2026, 19:46 UTC

Charlas de Mercado

FX Markets Taking Latest Trump Tariff Threat Calmly -- Market Talk

17 ene 2026, 15:06 UTC

Adquisiciones, fusiones, absorciones

Trump Purchased Netflix, Warner Bonds in Days After Deal Announcement -- Update

17 ene 2026, 03:10 UTC

Adquisiciones, fusiones, absorciones

Trump Purchased Netflix, Warner Bonds In Days After Deal Announcement -- WSJ

16 ene 2026, 22:48 UTC

Adquisiciones, fusiones, absorciones

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16 ene 2026, 22:43 UTC

Adquisiciones, fusiones, absorciones

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16 ene 2026, 22:22 UTC

Adquisiciones, fusiones, absorciones

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16 ene 2026, 21:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

16 ene 2026, 21:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Auto & Transport Roundup: Market Talk

16 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

16 ene 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

16 ene 2026, 21:48 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16 ene 2026, 21:41 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16 ene 2026, 21:38 UTC

Adquisiciones, fusiones, absorciones

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16 ene 2026, 21:30 UTC

Adquisiciones, fusiones, absorciones

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16 ene 2026, 21:30 UTC

Adquisiciones, fusiones, absorciones

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16 ene 2026, 21:30 UTC

Adquisiciones, fusiones, absorciones

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16 ene 2026, 21:30 UTC

Adquisiciones, fusiones, absorciones

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16 ene 2026, 21:30 UTC

Adquisiciones, fusiones, absorciones

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16 ene 2026, 20:44 UTC

Ganancias

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16 ene 2026, 20:42 UTC

Charlas de Mercado

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16 ene 2026, 20:28 UTC

Charlas de Mercado

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16 ene 2026, 19:12 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

Comparación entre iguales

Cambio de precio

Adaptive Biotechnologies Corp previsión

Precio Objetivo

By TipRanks

15.58% repunte

Estimación a 12 Meses

Media 20.25 USD 15.58%

Máximo 21 USD

Mínimo 20 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Adaptive Biotechnologies Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Adaptive Biotechnologies Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.81 / 10.18Soporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bullish.

There is one bullish event.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.